Global Therapeutic Biologics Market 2022-2028

According to latest analysis by Gen Consulting Company, the global therapeutic biologics market is poised to grow by USD 170 billion during 2022-2028, progressing at a CAGR of 7.7% during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global therapeutic biologics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the therapeutic biologics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, and region. The global market for therapeutic biologics can be segmented By product therapeutic proteins, vaccines, others. Among these, the therapeutic proteins segment was accounted for the highest revenue generator in 2021. Therapeutic biologics market is further segmented By region Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America is estimated to account for the largest share of the global therapeutic biologics market.

By product:
- therapeutic proteins
- vaccines
- others

By region:
- Asia Pacific
- Europe
- North America
- MEA (Middle East and Africa)
- Latin America

The report has also analysed the competitive landscape of the global therapeutic biologics market with some of the key players being Amgen Inc., Baxter International Inc., China Biologic ProductsHoldings, Inc., CSL Ltd., Eli Lilly and Company, GlaxoSmithKline plc (GSK plc), Grifols,S.A., Kedrion S.p.A., Novartis AG, Octapharma AG, Reliance Life Sciences, Roche Holding AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global therapeutic biologics market.
- To classify and forecast the global therapeutic biologics market based on product, region.
- To identify drivers and challenges for the global therapeutic biologics market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global therapeutic biologics market.
- To identify and analyze the profile of leading players operating in the global therapeutic biologics market.

Why Choose This Report
- Gain a reliable outlook of the global therapeutic biologics market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
Therapeutic proteins
Vaccines
Others
PART 6. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
MEA (Middle East and Africa)
Latin America
PART 7. KEY COMPANIES
Amgen Inc.
Baxter International Inc.
China Biologic ProductsHoldings, Inc.
CSL Ltd.
Eli Lilly and Company
GlaxoSmithKline plc (GSK plc)
Grifols,S.A.
Kedrion S.p.A.
Novartis AG
Octapharma AG
Reliance Life Sciences
Roche Holding AG
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Global Biobanking Market 2022-2028

Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. The global biobanking market

USD 2600 View Report

Global 3D Bioprinting Market 2022-2028

In 2021, the global 3d bioprinting market stood at USD 817 million. Recording a CAGR of 17.3% from 2022 to 2028, the worth is projected to reach ~USD 2,496 million

USD 2600 View Report

Global Therapeutic Protein Market Outlook

The global therapeutic protein market is estimated to grow at a CAGR of 9.6% during the forecast period. Therapeutic proteins are the developed proteins in the laboratory intended for pharmaceutical

USD 3950 View Report

Global Therapeutic Bed Market 2022-2028

According to latest analysis the global therapeutic bed market is projected to climb to USD 5,567 million by 2028-end, progressing at a CAGR of 5.3% during 2022-2028.The report provides in-depth

USD 2600 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available